Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Non-small Cell Lung Cancer|Breast Cancer|Prostate Cancer
Interventions: DRUG: imexon|DRUG: docetaxel
Sponsor: AmpliMed Corporation